José Z Parra Carrillo
University of Guadalajara
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by José Z Parra Carrillo.
American Journal of Hypertension | 1998
Cg Calvo-Vargas∗; José Z Parra Carrillo; Fernando Grover Páez; Salvador Fonseca Reyes
In developing countries, the cost of antihypertensive medications is one of the principal limiting factors when trying to treat patients with high blood pressure. To determine the changes in cost (in US dollars) of these medications and in the percentage of the minimum wage needed to purchase them, two cost studies (1990 and 1996) done in Mexico were compared. The yearly cost of a treatment with hydrochlorothiazide was US
Journal of Hypertension | 2013
Patricio López-Jaramillo; Ramiro Sanchez; Margarita Díaz; Leonardo Cobos; Alfonso Bryce; José Z Parra Carrillo; Fernando Lizcano; Fernando Lanas; Isaac Sinay; Iván D. Sierra; Ernesto Peñaherrera; Mario Bendersky; Helena Schmid; Rodrigo Botero; Manuel Urina; Joffre Lara; Milton Cesar Foss; Gustavo Márquez; Stephen B. Harrap; Agustin J. Ramirez; Alberto Zanchetti
13.80 in 1990; in 1996 it was US
Medicina interna de México | 2003
Salvador Fonseca Reyes; José Z Parra Carrillo
10.92. Both figures represent 1.1% of the minimum wage that was in effect at the time. Propranolol hydrochloride cost US
American Journal of Hypertension | 1998
Cg Calvo-Vargas∗; José Z Parra Carrillo; Fernando Grover Páez; Salvador Fonseca Reyes
50.52 for a years treatment in 1990, and US
Medicina interna de México | 2004
Salvador Fonseca Reyes; José Z Parra Carrillo
66.12 for the same in 1996. These figures represented, respectively, 4.2% and 6.7% of the minimum wage of 1990 and 1996. The annual cost for nifedipine was US
instname:Universidad de La Sabana | 2013
Patricio Lopez Jaramillo; Ramiro Sanchez; Margarita Díaz; Leonardo Cobos; Alfonso Bryce; José Z Parra Carrillo; Fernando Lizcano; Fernando Lanas; Isaac Sinay; Iván D. Sierra; Ernesto Peña Herrera; Mario Bendersky; Helena Schmid; Rodrigo Botero; Manuel Urina; Joffre Lara; Milton C. Foos; Gustavo Márquez; Stephen B. Harrap; Agustin J. Ramirez; Alberto Zanchetti
176.76 in 1990 (14.7% of the minimum wage) and US
Medicina Interna de México | 2006
Salvador Fonseca Reyes; Gustavo Zúñiga Sedano; Javier E García de Alba García; José Z Parra Carrillo; Sergio Ruiz Rosas
242.16 in 1996 (24.8% of the minimum wage). The yearly cost of enalapril was US
Medicina Interna de México | 2005
Salvador Fonseca Reyes; José Z Parra Carrillo
233.04 in 1990 and US
Variabilidad de la presión arterial mediante el uso de amlodipino utilizando monitoreo ambulatorio de la presión arterial | 2001
José Z Parra Carrillo; Irma Carolina Bonilla Rosales; Gabriela Ileana Ponce Martínez; Salvador Fonseca Reyes; Rodolfo Parra Michel; Elva Wendoline Rojo Contreras
433.20 in 1996; these costs represented, respectively, 19.4% and 44.2% of the minimum wage. The comparison of these two cost studies (1990 and 1996) shows why Mexicos population is finding it more difficult to purchase antihypertensive medications. Higher costs and reduced purchasing power seem to be the two principal factors causing this. This is probably affecting the populations health, as it is more difficult to control high blood pressure without proper treatment.
Nefrol. mex | 2001
Salvador Fonseca Reyes; José Z Parra Carrillo
